Revista nº 812

González Muñoz M, et al. | Efectividad terapias osteonecrosis de los maxilares Actual Med. 2021; 106(812): 66- 77 75 8. Yarom N, Yahalom R, Shoshani Y, Hamed W, Regev E, Elad S. Osteonecrosis of the jaw induced by orally admi- nistered bisphosphonates: incidence, clinical features, predisposing factors and treatment outcome. Osteopo- ros Int. 2007;18(10):1363-70. DOI: 10.1007/s00198- 007-0384-2 9. Boonyapakorn T, Schirmer I, Reichart PA, Sturm I, Mas- senkeil G. Bisphosphonate-induced osteonecrosis of the jaws: prospective study of 80 patients with multiple mye- loma and other malignancies. Oral Oncol. 2008;44(9):857- 69. DOI: 10.1016/j.oraloncology.2007.11.012 10. Angiero F, Sannino C, Borloni R, Crippa R, Benedicenti S, Romanos GE. Osteonecrosis of the jaws caused by bis- phosphonates: evaluation of a new therapeutic approach using the Er:YAG laser. Lasers Med Sci. 2009;24(6):849-56. DOI: 10.1007/s10103-009-0654-7 11. Junquera L, Gallego L, Cuesta P, Pelaz A, de Vicente JC. Clinical experiences with bisphosphonate-associated osteonecrosis of the jaws: analysis of 21 cases. Am J Otolaryngol. 2009;30(6):390-5. DOI: 10.1016/j.amjo- to.2008.07.014 12. Lazarovici TS, Yahalom R, Taicher S, Elad S, Hardan I, Ya- rom N. Bisphosphonate-related osteonecrosis of the jaws: a single-center study of 101 patients. J Oral Maxillofac Surg. 2009;67(4):850-5. DOI: 10.1016/j.joms.2008.11.015 13. Thumbigere-Math V, Sabino MC, Gopalakrishnan R, Huc- kabay S, Dudek AZ, Basu S, et al. Bisphosphonate-related osteonecrosis of the jaw: clinical features, risk factors, management, and treatment outcomes of 26 patients. J Oral Maxillofac Surg. 2009;67(9):1904-13. DOI: 10.1016/j. joms.2009.04.051 14. Scoletta M, Arduino PG, Dalmasso P, Broccoletti R, Moz- zati M. Treatment outcomes in patients with bisphos- phonate-related osteonecrosis of the jaws: a prospective study. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2010;110(1):46-53. DOI: 10.1016/j.tripleo.2010.02.020 15. Manfredi M, Merigo E, Guidotti R, Meleti M, Vescovi P. Bisphosphonate-related osteonecrosis of the jaws: a case series of 25 patients affected by osteoporosis. Int J Oral Maxillofac Surg. 2011;40(3):277-84. DOI: 10.1016/j. ijom.2010.11.002 16. Moretti F, Pelliccioni GA, Montebugnoli L, Marchetti C. A prospective clinical trial for assessing the efficacy of a minimally invasive protocol in patients with bisphospho- nate-associated osteonecrosis of the jaws. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2011;112(6):777-82. DOI: 10.1016/j.tripleo.2011.07.004 17. Mücke T, Koschinski J, Deppe H, Wagenpfeil S, Pautke C, Mitchell DA, Wolff KD, Hölzle F. Outcome of treatment and parameters influencing recurrence in patients with bis- phosphonate-related osteonecrosis of the jaws. J Can- cer Res Clin Oncol. 2011;137(5):907-13. DOI: 10.1007/ s00432-010-0953-1 18. Ferlito S, Puzzo S, Palermo F, Verzì P. Treatment of bis- phosphonate-related osteonecrosis of the jaws: presenta- tion of a protocol and an observational longitudinal study of an Italian series of cases. Br J Oral Maxillofac Surg. 2012;50(5):425-9. DOI: 10.1016/j.bjoms.2011.08.004 19. Freiberger JJ, Padilla-Burgos R, McGraw T, Suliman HB, Kraft KH, Stolp BW, et al. What is the role of hyperbaric oxygen in the management of bisphosphonate-related osteonecrosis of the jaw: a randomized controlled trial of hyperbaric oxygen as an adjunct to surgery and anti- biotics. J Oral Maxillofac Surg. 2012;70(7):1573-83. DOI: 10.1016/j.joms.2012.04.001 20. Jabbour Z, El-Hakim M, Mesbah-Ardakani P, Hender- son JE, Albuquerque R Jr. The outcomes of conservative and surgical treatment of stage 2 bisphosphonate-re- lated osteonecrosis of the jaws: a case series. Int J Oral Maxillofac Surg. 2012;41(11):1404-9. DOI: 10.1016/j. ijom.2012.05.012 21. Martins MA, Martins MD, Lascala CA, Curi MM, Migliora- ti CA, Tenis CA, et al. Association of laser phototherapy with PRP improves healing of bisphosphonate-related os- teonecrosis of the jaws in cancer patients: a preliminary study. Oral Oncol. 2012;48(1):79-84. DOI: 10.1016/j.ora- loncology.2011.08.010 22. Vescovi P, Merigo E, Meleti M, Manfredi M, Guidotti R, Nammour S. Bisphosphonates-related osteonecrosis of the jaws: a concise review of the literature and a report of a single-centre experience with 151 patients. J Oral Pathol Med. 2012;41(3):214-21. DOI: 10.1111/j.1600- 0714.2011.01091.x 23. Longo F, Guida A, Aversa C, Pavone E, Di Costanzo G, Ra- maglia L, et al. Platelet rich plasma in the treatment of bisphosphonate-related osteonecrosis of the jaw: per- sonal experience and review of the literature. Int J Dent. 2014;2014:298945. DOI: 10.1155/2014/298945 24. Lesclous P, Grabar S, Abi Najm S, Carrel JP, Lombardi T, Saffar JL, et al. Relevance of surgical management of pa- tients affected by bisphosphonate-associated osteone- crosis of the jaws. A prospective clinical and radiological study. Clin Oral Investig. 2014;18(2):391-9. DOI: 10.1007/ s00784-013-0979-2 25. Valente NA, Chatelain S, Alfonsi F, Mortellaro C, Barone A. Medication-Related Osteonecrosis of the Jaw: The Use of Leukocyte-Platelet-Rich Fibrin as an Adjunct in the Treatment. J Craniofac Surg. 2019;30(4):1095-1101. DOI: 10.1097/SCS.0000000000005475 26. Wutzl A, Biedermann E, Wanschitz F, Seemann R, Klug C, Baumann A, et al. Treatment results of bisphospho- nate-related osteonecrosis of the jaws. Head Neck. 2008;30(9):1224-30. DOI: 10.1002/hed.20864 27. Alons K, Kuijpers SC, de Jong E, van Merkesteyn JP. Trea- ting low- and medium-potency bisphosphonate-related osteonecrosis of the jaws with a protocol for the treat-